BlackRock, Inc. 13D and 13G filings for VistaGen Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-07-07 4:35 pm Sale | 2023-06-30 | 13G | VistaGen Therapeutics, Inc. VTGN | BlackRock Inc. BLK | 0 0.000% | -408,932 (Position Closed) | Filing |
| 2023-02-01 4:54 pm Purchase | 2022-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | BlackRock Inc. BLK | 408,932 5.900% | 12,459 (+3.14%) | Filing |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | BlackRock Inc. BLK | 396,473 6.000% | 396,473 (New Position) | Filing |